buprenorphine hydrochloride and naloxone hydrochloride dihydrate (West-Ward Pharmaceuticals Corp)
Welcome to the PulseAid listing for the buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug offered from West-Ward Pharmaceuticals Corp. This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | West-Ward Pharmaceuticals Corp |
| NON-PROPRIETARY NAME: | buprenorphine hydrochloride and naloxone hydrochloride dihydrate |
| SUBSTANCE NAME: | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-06-27 |
| END MARKETING DATE: | 0000-00-00 |
buprenorphine hydrochloride and naloxone hydrochloride dihydrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | buprenorphine hydrochloride and naloxone hydrochloride dihydrate from West-Ward Pharmaceuticals Corp |
| LABELER NAME: | West-Ward Pharmaceuticals Corp |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2014-06-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0054-0188_b222e7c9-fa8d-447d-9552-7d58cde5f85f |
| PRODUCT NDC: | 0054-0188 |
| APPLICATION NUMBER: | ANDA203326 |
Other BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
